New SERPINC1 gene mutations in patients with antithrombin deficiency: antithrombin Lodz I, II, III, and IV

Pol Arch Intern Med. 2022 Jan 28;132(1):16158. doi: 10.20452/pamw.16158. Epub 2021 Dec 1.

Authors

Weronika Nowak¹, Jacek Treliński², Ewa Wypasek^{3

4}, Belén de la Morena-Barrio⁵, María Eugenia de la Morena-Barrio⁵, Javier Corral⁵

Affiliations

¹ Copernicus Memorial Hospital, Łódź, Poland. sahel19@op.pl
² Department of Coagulation Disorders, Medical University of Lodz, Łódź, Poland
³ John Paul II Hospital, Kraków, Poland
⁴ Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Kraków University, Kraków, Poland
⁵ Regional Hemodonation Center, University of Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain

PMID: 34851072
DOI: 10.20452/pamw.16158

No abstract available

MeSH terms

Antithrombin III Deficiency* / genetics
Antithrombin III* / genetics
Fibrin
Humans
Mutation

Substances

SERPINC1 protein, human
Antithrombin III
Fibrin